It is also worth noting that these inhibitors have not been tested in tumors associated with endometriosis, but studies suggest that galectin inhibitors could be effective against these forms of cancer if they overexpress galectin-1 or galectin-3 [44]. The gene discussed is LGALS1; the disease is endometriosis.